[B033] 机构管线信息
获取机构管线信息,包括药物,靶点,适应症、研发状态等
返回结果中会包含子机构的管线, 并且会包含部分历史管线信息。
请求参数
此 API 接口支持的参数列表
| 名称 | 类型 | 示例 | 描述 |
|---|---|---|---|
| integer<int64> | - | 偏移量,默认0 |
| integer<int64> | 10 | 返回条数,默认10。 offset + limit <= 10000, limit最大设置1000 |
| string | 11ef8a9e8bf5ca80213a1183511cded3 | 机构ID |
响应结构
API 响应数据的结构说明
| 字段名 | 类型 | 示例 | 描述 |
|---|---|---|---|
data | object | - | 响应数据 |
items | array | Please check the form:PipelineDto | 查询结果 |
drug | object | {
"drug_id": "d93ac663566e463a8a1ed670ff80e37d",
"display_name": [
{
"lang": "EN",
"name": "Ustekinumab biosimilar (Amgen)"
},
{
"lang": "CN",
"name": "乌司奴单抗生物类似药(Amgen)"
}
]
} | 药物 |
drug_id | string | e82b83b42eba4e5ea3f26f8e06081a5a | 药物ID |
display_name | array | [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
},
{
"lang": "CN",
"name": "雷珠单抗"
}
] | 药物名称,引用“CommonName” |
lang | string | EN | 语言 |
name | string | Ranibizumab (Genentech) | 药物、靶点、机构、适应症、国家/地区、字典、作用机制 名称 |
target | object | {
"target_id": "91ca1aaf98ed318e99cee1e186a0da7c",
"short_name": [
{
"lang": "EN",
"name": "IL-12 x IL-23"
},
{
"lang": "CN",
"name": "IL-12 x IL-23"
}
],
"display_name": [
{
"lang": "EN",
"name": "IL-12 x IL-23"
},
{
"lang": "CN",
"name": "IL-12 x IL-23"
}
]
} | 靶点 |
target_id | string | 1c2067e5ab054a8995f73efcfcf56207 | 靶点ID |
short_name | array | [
{
"lang": "EN",
"name": "VEGF"
}
] | 靶点简称,引用“CommonName” |
display_name | array | [
{
"lang": "EN",
"name": "Vascular endothelial growth factor"
},
{
"lang": "CN",
"name": "血管内皮生长因子"
}
] | 靶点全称,引用“CommonName” |
country | object | {
"country_id": "0dc5d896-7408-3c87-84c0-22e3d9b784be",
"alpha2_code": "US",
"display_name": [
{
"lang": "EN",
"name": "United States"
},
{
"lang": "CN",
"name": "美国"
}
]
} | 国家/地区 |
country_id | string | 676de5ba-893a-36bb-8683-c93306aaf769 | 国家地区ID |
alpha2_code | string | US | 国家编码 |
display_name | array | [
{
"lang": "EN",
"name": "United States"
},
{
"lang": "CN",
"name": "美国"
}
] | 国家地区名称 |
disease | object | {
"disease_id": "05ae12d567784b85a5c1ca54b2063ee2",
"display_name": [
{
"lang": "EN",
"name": "Crohn Disease"
},
{
"lang": "CN",
"name": "克罗恩病"
}
]
} | 适应症 |
disease_id | string | 06a9082fe1ec4c97bea31d888b9cfdce | 适应症ID |
display_name | array | [
{
"lang": "EN",
"name": "Uveitic Macular Edema"
},
{
"lang": "CN",
"name": "葡萄膜炎黄斑水肿"
}
] | 适应症名称,引用“CommonName” |
data_type | string | Current | Current:进行中的管线;History:非进行中的管线 |
drug_type | array | [
{
"display_name": [
{
"lang": "EN",
"name": "Biosimilar"
},
{
"lang": "CN",
"name": "生物类似药"
}
],
"normalized_id": "9f2e2934e5b2477e916cdbedf928934b"
},
{
"display_name": [
{
"lang": "EN",
"name": "Monoclonal antibody"
},
{
"lang": "CN",
"name": "单克隆抗体"
}
],
"normalized_id": "c38eb408d6b842f487d6a27484156633"
}
] | 药物类型 |
display_name | array | [
{
"lang": "EN",
"name": "Autologous CAR-T"
},
{
"lang": "CN",
"name": "自体CAR-T"
}
] | 字典名称 |
normalized_id | string | 2fbfdb3e92d942c48cbb0adb79f23526 | 字典ID |
dev_status | object | {
"display_name": [
{
"lang": "EN",
"name": "Approved"
},
{
"lang": "CN",
"name": "批准上市"
}
],
"normalized_id": "efd6215835394b07b046125e3175d3fe"
} | Dev Status |
dev_status_time | integer<int64> | 1698710400000 | 时间 |
therapeutic_area | array | {
"drug_id": "d93ac663566e463a8a1ed670ff80e37d",
"display_name": [
{
"lang": "EN",
"name": "Ustekinumab biosimilar (Amgen)"
},
{
"lang": "CN",
"name": "乌司奴单抗生物类似药(Amgen)"
}
]
} | 治疗领域 |
limit | integer<int64> | 10 | 返回条数 |
total | integer<int64> | 10 | 总量 |
offset | integer<int64> | - | 偏移量 |
status必填 | boolean | false | 状态 |
error_msg | string | The request parameter format is incorrect! | 错误信息 |
error_code必填 | integer | 0 | 错误代码 |
成功响应示例
成功调用 API 的响应示例
JSON
{
"data": {
"items": [
{
"drug": {
"drug_id": "e82b83b42eba4e5ea3f26f8e06081a5a",
"display_name": [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
}
]
},
"target": {
"target_id": "1c2067e5ab054a8995f73efcfcf56207",
"short_name": [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
}
],
"display_name": [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
}
]
},
"country": {
"country_id": "676de5ba-893a-36bb-8683-c93306aaf769",
"alpha2_code": "US",
"display_name": [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
}
]
},
"disease": {
"disease_id": "06a9082fe1ec4c97bea31d888b9cfdce",
"display_name": [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
}
]
},
"data_type": "Current",
"drug_type": [
{
"display_name": [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
}
],
"normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
}
],
"dev_status": {
"display_name": [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
}
],
"normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
},
"dev_status_time": 1698710400000,
"therapeutic_area": [
{
"disease_id": "06a9082fe1ec4c97bea31d888b9cfdce",
"display_name": [
{
"lang": "EN",
"name": "Ranibizumab (Genentech)"
}
]
}
]
}
],
"limit": 10,
"total": 10,
"offset": 0
},
"status": true,
"error_code": 0
}错误码
此接口可能返回的错误码列表
业务错误码
| 错误码 | 描述 |
|---|---|
68300004 | 请求参数异常! |
68300005 | 查询Api失败! |
68300006 | 解析基本存取错误! |
68300007 | 存在错误的请求! |
68300008 | 服务中断异常,请稍后再试! |
68300010 | 文件不符合上传规范! |
平台错误码
| 错误码 | 描述 |
|---|---|
67200001 | API整体限流错误! |
67200002 | 用户调用请求限流限制错误! |
67200003 | 申请token的key和secret不正确或者状态错误! |
67200004 | 无权限或该接口的套餐已超过系统设置的上限! |
67200005 | 账户余额不足,调用失败! |
67200006 | 客户端已过期,调用失败! |
67200007 | 超过调用额度,调用失败! |
HTTP 状态码
| 状态码 | 描述 |
|---|---|
0 | 请求成功 |
201 | Created |
401 | Unauthorized |
403 | Forbidden |
404 | Not Found |
性能指标
此接口的预期性能特征
正常响应时间
5000 ms
最大响应时间
10000 ms